Bortezomib a Safe Treatment for Patients with Multiple Myeloma and Cystic Fibrosis

INTRODUCTION: Bortezomib is a proteasome inhibitor that targets myeloma cell and its bone marrow microenvironment. Intravenous Bortezomib with or without dexamethasone, is effective and well tolerated in patients with relapsed/refractory multiple myeloma (MM). METHODS: We used Bortezomib without cor...

Descripción completa

Detalles Bibliográficos
Autores principales: Gentilini, Fabiana, Levi, Anna, Federico, Vincenzo, Russo, Eleonora, Foà, Robin, Petrucci, Maria Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375716/
https://www.ncbi.nlm.nih.gov/pubmed/22708050
http://dx.doi.org/10.4084/MJHID.2012.035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375716/
https://www.ncbi.nlm.nih.gov/pubmed/22708050
http://dx.doi.org/10.4084/MJHID.2012.035

Ejemplares similares